Taxotere Mass Tort Case Leads
Connect with cancer survivors left with permanent hair loss or chronic eye-tearing after Taxotere chemotherapy.
Taxotere (Docetaxel) Permanent Hair Loss & Eye Injury Litigation
Taxotere (docetaxel) is a taxane chemotherapy drug made by Sanofi-Aventis and widely used to treat breast and other cancers. Lawsuits allege the manufacturer failed to warn patients and doctors that the drug can cause permanent, irreversible hair loss (alopecia) and disfiguring eye injuries such as canalicular stenosis (tear-duct scarring) and chronic excessive tearing. The permanent hair loss claims are consolidated in federal MDL 2740 and the newer eye injury claims in MDL 3023, both before Judge Jane Triche Milazzo in the Eastern District of Louisiana. As of 2026 the litigation remains active with no global settlement, and attorneys are still reviewing new claims.
Associated Conditions
- Permanent, irreversible hair loss (persistent alopecia) lasting 6+ months after chemotherapy
- Failure of hair to regrow on the scalp, eyebrows, eyelashes, or body
- Canalicular stenosis (narrowing or blockage of the tear ducts)
- Chronic excessive watery eyes / persistent tearing (epiphora)
- Eye irritation, recurrent infections, or blurred vision
- Tear-duct damage requiring corrective surgery such as dacryocystorhinostomy (DCR)
Claimant Eligibility
- Were treated with Taxotere or generic docetaxel, typically for breast or another cancer
- Developed permanent hair loss or a qualifying eye injury (canalicular stenosis/chronic tearing) after treatment
- The injury persisted well beyond completion of chemotherapy (generally 6 months or longer)
- Have or can obtain medical and pharmacy records documenting the treatment and diagnosis
- Have not already settled or filed a separate claim for the same injury
Why Law Firms Choose Us
Exclusive Leads
Every lead is yours alone. We never resell or share claimant information with competing firms, guaranteeing you first-mover advantage on every case.
Pre-Qualified Claimants
Our intake specialists screen every potential claimant against your specific case criteria before delivery, so your team only speaks with viable cases.
Live Transfer
Qualified claimants are transferred directly to your intake team in real time, maximizing conversion rates and reducing time-to-retainer.
Taxotere legal marketing campaigns: how we acquire cases
Taxotere case acquisition runs as a multi-channel program, not a single ad buy. Product liability and class action claimants research their condition long before they contact a lawyer, so we meet potential clients at each stage — paid demand capture for people already searching, paid social and traditional media for people who have not yet connected their injury to the litigation, and organic search for the long research tail.
Digital marketing channels
- Google Ads and paid search demand capture
- Meta and paid social prospecting by exposure profile
- Mass tort search engine optimization for the research tail
- OTT and connected TV retargeting
Traditional media channels
- Broadcast and cable TV in qualifying DMAs
- Radio and streaming audio
- Direct response print in occupational verticals
- Earned media and litigation PR support
How the channel mix is built, budgeted, and measured is covered in our mass tort marketing guide. For intake handling once the lead lands, see mass tort intake.
Running a Taxotere mass tort marketing campaign
Common questions from law firms about Taxotere lawsuit lead generation and campaign management.
- What does a Taxotere mass tort marketing campaign include?
- A Taxotere mass tort marketing campaign from Mass Tort Marketing Agency covers multi-channel strategy across Meta, Google PPC, OTT and connected TV, traditional media, and mass tort search engine optimization; compliant ad creative; TCPA-verified intake; claimant qualification against your Taxotere case criteria; and signed-retainer reporting. Performance is measured on cost per signed retainer, not raw lead volume.
- How do you generate Taxotere mass tort case leads?
- Taxotere mass tort case leads are generated through paid social and search campaigns aimed at the specific exposure and injury profile of the litigation, supported by organic content that captures claimants already researching their condition. Every lead is a real, consented claimant — we do not buy aggregated lists or resell shared data.
- What do Taxotere legal marketing campaigns cost?
- Taxotere legal marketing campaigns are quoted and reported on cost per signed retainer (CPSR), so spend ties directly to signed cases rather than lead count. Cost per retainer varies by tort based on claimant prevalence, media competition, and how tight your case criteria are. We scope a per-tort figure before any spend commitment.
- Are Taxotere leads exclusive to my firm?
- Yes. Every Taxotere lead is delivered to one firm only — never resold, syndicated, or shared with competing firms. Your firm owns the contact data, consent records, and call recordings.
- How are Taxotere claimants qualified before delivery?
- Each Taxotere claimant is screened against tort-specific facts (exposure windows, injury markers, and state eligibility) and carries a certified TrustedForm or Jornaya consent record — preserving the exact disclosure language shown at submission — before the lead reaches your intake team.
- How fast can a Taxotere case acquisition program scale?
- A Taxotere mass tort case acquisition program typically moves from scoping to live media inside two weeks, with volume ramped against your docket capacity rather than pushed to a fixed budget. Volume can be scaled up or down by tort month to month as the litigation posture changes.
Get Taxotere campaign pricing on a 30-minute call
We will walk your Taxotere case criteria, current cost per signed retainer, and the volume your docket can absorb — and tell you plainly if this tort is not a fit right now.
See how every lead is qualified on our mass tort leads page, read the full mass tort marketing guide, or compare providers in our top mass tort marketing firms guide.